Skip to main content

SSO 2024 Annual Meeting Main banner

Tweets by SSO 2024 Annual Meeting

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Recorded for On-Demand Viewing

Recorded for On-Demand Viewing

Back

Tweet

Fatima Cardoso, n/a

Champalimaud Clinical Centre
Champalimaud Foundation, Lisbon, Portugal, United States

Presentation(s):

2: Phase 3 study of neoadjuvant pembrolizumab or placebo + chemotherapy, followed by adjuvant pembrolizumab or placebo plus endocrine therapy for early-stage high-risk ER+/HER2− breast cancer: KEYNOTE-756

Friday, March 22, 2024
1:14pm – 1:26pm ET